DENVER, June 14, 2016 /PRNewswire/ -- Philips
Respironics, a division of Royal Philips (NYSE: PHG, AEX: PHIA),
today introduced Patient Adherence Management Service (PAMS), which
will support new patients' transition to sleep therapy. PAMS is on
display during this year's SLEEP 2016 event (June 11-15) along with several leading health
solutions that demonstrate Philips' commitment to expanding its
successful connectivity model in sleep and respiratory care. With
more than 10 years of cloud-based data sharing experience and
analytics for more than 7 million patient lives, Philips has a long
history of leading new innovation in informatics to help patients
sleep and breathe better.
PAMS utilizes Philips Respironics' EncoreAnywhere software,
DreamStation PAP therapy devices, Philips' portfolio of masks and
the DreamMapper patient engagement application. PAMS is a concrete
example of how Philips' connected care management solutions help
provide customers with insight and the necessary tools to enhance
overall patient care.
"For years, Philips Respironics has provided innovative
solutions to help patients with sleep and breathing disorders,
always leveraging technology to make therapy feel as natural as
possible," said Dr. Aloia, Vice President and Global Lead, Behavior
Change, Philips. "Our innovations are connected to intuitively work
together at every phase of the health continuum and are designed to
enable exceptional outcomes in patient adherence. With this new
connected management service, our goal is to help patients fully
engage with and adapt to their therapy, ultimately helping them
live healthier lives."
Better sleep therapy adherence and patient
satisfaction
Developed as a result of input from homecare providers looking
for additional support to improve sleep patient adherence, Philips'
Patient Adherence Management Service has been shown to boost
adherence rates of CPAP patients by an average of 49 percent[2].
PAMS leverages Philips' deep knowledge of sleep apnea and the data
of millions of patients who have been managed by EncoreAnywhere,
the world's most widely-used patient compliance management
system.
PAMS has shown to improve adherence rates up to 24 percent
within the first 90 days, and at least 16 percent or more in the
first 30 days of therapy[3]. PAMS aims to not only help improve
compliance rates, but improve the experience of new patients
attempting to adapt to therapy. Key components of the PAMS program,
include:
- Patient Outreach Protocol: This includes personalized
calls, emails and texts to deliver education, motivational
reminders and support from sleep coaches and respiratory therapists
trained in health behavior change;
- EncoreAnywhere Software and Predictive Modeling:
PAMS uses this software for workflow and communications with
homecare providers, helping to identify patients struggling with
therapy adoption and personalize coaching;
- Dream Family Connectivity: PAMS uses the
DreamStation PAP device (connected via cell or Wi-Fi), Philips'
masks and the DreamMapper patient engagement app.
Solutions that address adherence, provide
efficiencies
PAMS is just the latest in applied-data solutions from Philips
that build on the company's longstanding commitment to creating
solutions that help better manage sleep and respiratory conditions
and improve patient care. Philips' track record in providing
connected solutions can be seen in additional technologies that are
on-site during SLEEP 2016, including the Care Orchestrator care
management application. The first-of-its-kind connected health
technology for sleep and respiratory conditions, Care Orchestrator
allows patients to stay connected to their care teams throughout
the course of therapy. It is the next generation of EncoreAnywhere,
and enables data, clinical management workflow, informatics and
intelligence for providers, payers and patients within a single
cloud-based platform. A full range of Philips sleep and respiratory
devices, including DreamStation BiPAP ASV and BiPAP AVAPS, Trilogy,
EverFlo, SimplyGo and iNeb, are planned to connect to Care
Orchestrator and tie into the Philips HealthSuite cloud
platform.
Visitors can view a demonstration of PAMS at the Philips
Respironics booth 101. Additionally, during the show, Philips
Respironics' employees and partners presented the following:
- "Adherence to Positive Airway Pressure Therapy with a
Structured Adherence Program"
William
Hardy, RRT, presented a Poster Abstract on Clinical Sleep
research that analyzed the impact of a structured patient adherence
management program on patient adherence to CPAP therapy. The
session was held on Sunday, June 12,
5:00 p.m. – 7:00 p.m. in the Poster Hall.
- "Bringing Behavior Change Psychology into Digital Solutions
at Philips Respironics"
Mark
Aloia, PhD, spoke about the use of structured patient
adherence programs and technology to improve patient adherence in
CPAP therapy. The session was held on Monday, June 13, 12:30
p.m. at Philips Booth 101.
For updates on Philips' presence at SLEEP 2016, visit
http://philips.to/1sdjDqI. For more information on Philips advanced
solutions for sleep and respiratory care and updates from the show,
follow @PhilipsResp and the Philips Respironics Facebook.
For further information, please contact:
Alicia Cafardi
Philips
alicia.cafardi@philips.com
724-387-4439
About Royal Philips
Royal Philips (NYSE: PHG, AEX:
PHIA) is a leading health technology company focused on improving
people's health and enabling better outcomes across
the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to
deliver integrated solutions. The company is a leader in
diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as
in consumer health and home care.
Headquartered in the Netherlands,
Philips' health technology portfolio generated 2015 sales of
EUR 16.8 billion and employs
approximately 69,000 employees with sales and services in more than
100 countries. News about Philips can be found at
www.philips.com/newscenter.
[1] Retrospective study using 2014 -2016 EncoreAnywhere data
from 12 Home Care Providers that used PAMS for at least six months.
CMS Compliance definition - minimum of 4 hours of use over 70% of
the nights during a consecutive 30 day period within the first 90
days of use.
[2] Retrospective study using 2014 -2016 EncoreAnywhere data
from 12 Home Care Providers that used PAMS for at least six months.
CMS Compliance definition - minimum of 4 hours of use over 70% of
the nights during a consecutive 30 day period within the first 90
days of use.
[3] Retrospective study using 2014 -2016 EncoreAnywhere data
from 12 Home Care Providers that used PAMS for at least six months.
CMS Compliance definition - minimum of 4 hours of use over 70% of
the nights during a consecutive 30 day period within the first 90
days of use.
Logo -
http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-debuts-connected-management-solution-using-cloud-based-data-to-support-treatment-adherence-for-sleep-and-respiratory-patients-300284338.html
SOURCE Royal Philips